Based on the hypothesis that PI3K/AKT pathway inhibitors may target neoplastic-stemness cells, gene expression data and drug sensitivity (IC50 values) for GBM cell lines were obtained from the Cancer Drug Sensitivity in Genomics (GDSC) database [42]. Here, AKT1 is linked to glioblastoma.